| Biological Sciences | Lifetime | 198 | BE 4 | 99.97 |
| Cancer Research | Lifetime | 9 | BE 1 | 99.96 |
| Molecular Biology | Lifetime | 135 | BE 1 | 99.94 |
| Hematology | Lifetime | 234 | BE 2 | 98.68 |
| Cellular and Molecular Neuroscience | Lifetime | 764 | BE 3 | 96.42 |
| Obstetrics and Gynecology | Lifetime | 807 | BE 16 | 88.31 |
| Immunology and Allergy | Lifetime | 701 | BE 6 | 85.32 |
| Molecular Biology | 2021-2025 | 725 | BE 4 | 96.02 |
| Cancer Research | 2021-2025 | 155 | BE 4 | 91.91 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 4 | BE 1 | 99.99 |
| Angiogenesis and VEGF in Cancer | Lifetime | 2 | BE 1 | 99.98 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 4 | BE 1 | 99.85 |
| Protease and Inhibitor Mechanisms | Lifetime | 5 | BE 1 | 99.90 |
| Apelin-related biomedical research | Lifetime | 3 | BE 1 | 99.65 |
| Kruppel-like factors research | Lifetime | 7 | BE 1 | 99.64 |
| Axon Guidance and Neuronal Signaling | Lifetime | 12 | BE 1 | 99.64 |
| Congenital heart defects research | Lifetime | 28 | BE 1 | 99.53 |
| Zebrafish Biomedical Research Applications | Lifetime | 12 | BE 1 | 99.46 |
| Cell Adhesion Molecules Research | Lifetime | 119 | BE 3 | 99.49 |
| Cancer, Lipids, and Metabolism | Lifetime | 185 | BE 3 | 99.14 |
| Immune cells in cancer | Lifetime | 230 | BE 7 | 98.63 |
| Signaling Pathways in Disease | Lifetime | 138 | BE 3 | 98.17 |
| Cancer Cells and Metastasis | Lifetime | 438 | BE 11 | 98.11 |
| Lymphatic System and Diseases | Lifetime | 99 | BE 2 | 97.15 |
| Phagocytosis and Immune Regulation | Lifetime | 139 | BE 8 | 97.26 |
| Single-cell and spatial transcriptomics | Lifetime | 297 | BE 4 | 96.12 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 419 | BE 1 | 97.40 |
| High Altitude and Hypoxia | Lifetime | 378 | BE 4 | 95.51 |
| Hemophilia Treatment and Research | Lifetime | 439 | BE 4 | 94.92 |
| S100 Proteins and Annexins | Lifetime | 874 | BE 11 | 93.19 |
| Fibroblast Growth Factor Research | Lifetime | 664 | BE 4 | 92.39 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 680 | BE 14 | 93.52 |
| Cardiac Fibrosis and Remodeling | Lifetime | 636 | BE 9 | 92.54 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 577 | BE 5 | 90.93 |
| Adrenal Hormones and Disorders | Lifetime | 993 | BE 13 | 91.79 |
| Cerebrovascular and genetic disorders | Lifetime | 606 | BE 6 | 81.78 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 29 | BE 2 | 98.55 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 4 | BE 1 | 98.80 |
| Single-cell and spatial transcriptomics | 2021-2025 | 109 | BE 2 | 96.80 |
| Immune cells in cancer | 2021-2025 | 282 | BE 3 | 94.59 |
| Fibroblast Growth Factor Research | 2021-2025 | 810 | BE 4 | 60.03 |
| Zebrafish Biomedical Research Applications | 2021-2025 | 918 | BE 5 | 57.96 |
| Barrier Structure and Function Studies | 2021-2025 | 974 | BE 4 | 42.96 |
